|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ݡ���� |
|
���� |
|
ҩ������ |
| ��������������� | |
|
������ |
|
��¡�� |
|
�Խ��� |
|
��ǧ�� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
|
Article by |
�����ط���ݡ�����ҩ�����ƽ�չ
������, ��¡��, �Խ���, ��ǧ��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ�210042
�����ط���ݡ�����ҩ�����ƽ�������һ���Ľ�չ,�������鰷H1������������,���Ƴ��˸�Ч����ȫ���Ƽ����鰷H1����������Ȼ�����������ط���ݡ�������ѡҩ��;�����鰷H1���������ֿ��������ط���ݡ�����,�û����ء���Ƥ�ʼ��ػ����ϰ���ϩ�����������ƿ��Ի��һ������Ч;���ڰ���������Ⱦ�Ի����������Լ����Ļ���,������Ӧ�ĺϲ�֢�����Ӹ��������������ط���ݡ���
[2] Gelfand EW, Appajosyula S, Meeves S. Anti-inflammatory activity of H1-R receptor antagonists:review of recent experimental research. Curr Med Res Opin, 2004, 20:73-81.
[3] Kawashima M, Harada S, Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol, 2002, 41:701-781.
[4] Ring J, Hein R, Gauger A, et al. Once-R daily desloratadine inproves the signs and symptoms of chronic idiopathic urticaria:a randomized, double-R blind, placebo-R controlled study. Int J Dermatol, 2001, 40:72-76.
[5] Valk PJ, Van Roon DB, Simons RM, et al. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude. Aviat Space Environ Med, 2004, 75:433-438.
[6] Henz BM. The pharmacologic profile of desloratadine:a review. Allergy, 2001, 56(Suppl65):7-13.
[7] Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-R controlled trial comparing desloratadine and montelukast in monotherapy and desioratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol, 2004,114:619-625.
[8] Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria:a single-R blind, placeboR controlled, crossover clinical study. J Allergy Clin Immunol,2002, 110:484-488.
[9] Loria MP, Dambra PP, D'Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria:a therapeutic alternative.Immunopharmacol Immunotoxicol, 2001, 23:205-213.
[10] Baskan EB, Tunali S, Turker T, et al. Comparison of short-R and long-R term cyclosporine A therapy in chronic idiopathic urticaria.J Dermatolog Treat, 2004, 15:164-168.
[11] Grattan CE, O'Donnell BF, Francis DM, et al. Randomized doubleR blind study of cyclosporin in chronic "idiopathic"urticaria. Br J Dermatol, 2000, 143:365-372.
[12] Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria:a double blind, placebo controlled trial. J Dermatol, 2001, 28:299-302.
[13] Paradis L, Lavoie A, Brunet C, et al. Effects of systemic corticosteroids on cutaneous histamine secretion and histamine-R releasing factor in patients with chronic idiopathic urticaria. Clin Exp Allergy, 1996, 26:815-820.
[14] Zauli D, Grassi A, Ballardini G, et al. Thyroid autoimmunity in chronic idiopathic urticaria:implications for therapy. Am J Clin Dermatol, 2002, 3:525-528.
[15] Gaig P, Garcia-R Ortega P, Enrique E, et al. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity.J Investig Allergol Clin Immunol, 2000, 10:342-345.
[16] Moreira A, Rodrigues J, Delgado L, et al. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr), 2003, 31:209-214.
[17] Parslew R, Pryce D, Ashworth J,et al. Warfarin treatment of chronic idiopathic urticaria and angio-R oedema. Clin Exp Allergy, 2000,30:1161-1165.